ADMA ADMA Biologics, Inc. Stock Quote

ADMA [NASD]

Index	-	P/E	-	EPS (ttm)	-0.42	Insider Own	2.10%	Shs Outstand	196.35M	Perf Week	5.68%
Market Cap	524.44M	Forward P/E	-	EPS next Y	-0.20	Insider Trans	0.00%	Shs Float	175.65M	Perf Month	34.78%
Income	-73.10M	PEG	-	EPS next Q	-0.07	Inst Own	74.70%	Short Float	16.09%	Perf Quarter	38.81%
Sales	110.10M	P/S	4.76	EPS this Y	41.60%	Inst Trans	11.78%	Short Ratio	10.42	Perf Half Y	64.12%
Book/sh	0.58	P/B	4.81	EPS next Y	39.40%	ROA	-26.10%	Target Price	4.67	Perf Year	119.69%
Cash/sh	0.28	P/C	10.01	EPS next 5Y	-	ROE	-60.30%	52W Range	1.01 - 2.85	Perf YTD	97.87%
Dividend	-	P/FCF	-	EPS past 5Y	20.40%	ROI	-24.70%	52W High	0.70%	Beta	0.93
Dividend %	-	Quick Ratio	2.70	Sales past 5Y	50.00%	Gross Margin	13.90%	52W Low	184.16%	ATR	0.15
Employees	527	Current Ratio	7.90	Sales Q/Q	90.40%	Oper. Margin	-52.90%	RSI (14)	66.26	Volatility	6.76% 6.69%
Optionable	Yes	Debt/Eq	1.22	EPS Q/Q	52.80%	Profit Margin	-66.40%	Rel Volume	1.83	Prev Close	2.79
Shortable	Yes	LT Debt/Eq	1.22	Earnings	Aug 10 AMC	Payout	-	Avg Volume	2.71M	Price	2.87
Recom	1.70	SMA20	12.24%	SMA50	24.19%	SMA200	56.36%	Volume	984,027	Change	2.87%

Nov-11-21

Upgrade

Raymond James

Outperform → Strong Buy

Nov-09-21

Initiated

Cantor Fitzgerald

Overweight

$4.50

Jun-04-19

Initiated

Jefferies

Buy

Apr-15-19

Reiterated

H.C. Wainwright

Buy

$10 → $13

Feb-07-19

Resumed

H.C. Wainwright

Buy

$10

Dec-11-17

Reiterated

Maxim Group

Buy

$13 → $8

Nov-14-17

Upgrade

Raymond James

Mkt Perform → Outperform

Jan-23-17

Upgrade

Maxim Group

Hold → Buy

$13

Aug-01-16

Downgrade

Maxim Group

Buy → Hold

Jul-25-16

Reiterated

Maxim Group

Buy

$24 → $14

May-13-15

Reiterated

Maxim Group

Buy

$18 → $24

Dec-08-14

Initiated

Oppenheimer

Outperform

$20

Dec-01-14

Reiterated

Maxim Group

Buy

$16 → $18

Aug-31-22 04:55PM	Top Penny Stocks for September 2022 Investopedia
Aug-11-22 06:08PM	Why ADMA Biologics Stock Triumphed on Thursday Motley Fool +5.19%
Aug-10-22 05:25PM	Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
07:16AM	ADMA Biologics, Inc. (NASDAQ:ADMA) insiders placed bullish bets worth US$580k in the last 12 months Simply Wall St.
Aug-08-22 10:00AM	Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for Zacks
Aug-03-22 10:00AM	Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
07:00AM	ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022 GlobeNewswire
Jun-26-22 09:11AM	Shareholders in ADMA Biologics (NASDAQ:ADMA) have lost 50%, as stock drops 12% this past week Simply Wall St.
Jun-21-22 07:00AM	ADMA Biologics Announces Addition to the Russell 2000® Index GlobeNewswire
May-11-22 05:45PM	Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates Zacks -11.18%
04:05PM	ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
May-10-22 06:30AM	What Kind Of Shareholders Own ADMA Biologics, Inc. (NASDAQ:ADMA)? Simply Wall St.
May-04-22 08:25AM	Moderna (MRNA) Q1 Earnings and Revenues Top Estimates Zacks
07:00AM	ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022 GlobeNewswire
Apr-17-22 08:59AM	ADMA Biologics, Inc. (NASDAQ:ADMA): When Will It Breakeven? Simply Wall St.
Apr-01-22 07:00AM	ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV at CIS 2022 GlobeNewswire
Mar-25-22 07:00AM	ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV & BIVIGAM® from 24 to 36 Months GlobeNewswire +8.67%
Mar-24-22 05:35PM	Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM	ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management GlobeNewswire
Mar-21-22 07:00AM	ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 GlobeNewswire -8.77%
Mar-07-22 04:05PM	ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA GlobeNewswire
Mar-03-22 04:27AM	ADMA Biologics, Inc. (NASDAQ:ADMA) insiders placed bullish bets worth US$580k in the last 12 months Simply Wall St.
Jan-19-22 07:00AM	ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update GlobeNewswire
Jan-18-22 07:00AM	ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC GlobeNewswire
Jan-17-22 04:22AM	ADMA Biologics (NASDAQ:ADMA) investors are sitting on a loss of 72% if they invested five years ago Simply Wall St.
Jan-12-22 09:38AM	Hikari Power Ltd Buys Alphabet Inc, Vanguard Health Care ETF, Bristol-Myers Squibb Co, Sells ... GuruFocus.com -5.19%
Dec-29-21 10:53AM	These 2 Strong Buy Penny Stocks Are Poised to Take Off, Says Raymond James TipRanks +8.33%
Dec-21-21 07:00AM	ADMA Biologics Adopts Limited Duration Stockholder Rights Plan GlobeNewswire
Dec-10-21 11:24AM	Implied Volatility Surging for ADMA Biologics (ADMA) Stock Options Zacks
10:17AM	Community Health (CYH) Up 64% YTD: More Growth Potential Left? Zacks
Dec-09-21 07:00AM	ADMA Biologics Provides Update on Global Intellectual Property Portfolio GlobeNewswire
Dec-07-21 04:56PM	Find Strong Cheap Stocks Under $10 to Buy in December Zacks +6.25%
Nov-17-21 07:00AM	ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors GlobeNewswire
Nov-16-21 07:00AM	ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC GlobeNewswire
Nov-11-21 07:49AM	ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double Benzinga +13.57%
Nov-10-21 09:00PM	ADMA Biologics Inc (ADMA) Q3 2021 Earnings Call Transcript Motley Fool
05:35PM	Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments GlobeNewswire
Nov-03-21 07:00AM	ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021 GlobeNewswire +5.67%
Oct-28-21 03:06PM	Will Adma Biologics (ADMA) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-27-21 05:27AM	3 Penny Stocks Insiders Are Buying Benzinga
Oct-25-21 04:01PM	ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Oct-22-21 07:00AM	ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference GlobeNewswire +5.79%
Oct-21-21 12:28PM	38 Stocks Moving In Thursday's Mid-Day Session Benzinga +9.01%
09:00AM	ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock GlobeNewswire
Oct-20-21 04:01PM	ADMA Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Oct-19-21 07:00AM	ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference GlobeNewswire
Oct-18-21 07:00AM	ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D. GlobeNewswire
Oct-04-21 07:00AM	ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021 GlobeNewswire
Oct-01-21 11:11AM	Adma Biologics Insider Trades $300K In Company Stock Benzinga +5.31%
07:00AM	ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021 GlobeNewswire
Sep-30-21 11:16AM	10% Owner Of Adma Biologics Sold $620K In Stock Benzinga
Sep-29-21 02:27PM	Is ADMA Biologics Inc (ADMA) A Good Stock To Buy? Insider Monkey -7.38%
Sep-23-21 07:00AM	ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference GlobeNewswire
Sep-08-21 08:08AM	ADMA Biologics' Aseptic Fill-Finish Machine Scores FDA Approval Benzinga -7.09%
07:00AM	ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations GlobeNewswire
Sep-02-21 07:00AM	ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference GlobeNewswire
Aug-20-21 08:03AM	4 Stocks Insiders Are Selling Benzinga
Aug-16-21 08:27AM	ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility Benzinga
07:00AM	ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN GlobeNewswire
Aug-12-21 12:00PM	ADMA Biologics Inc (ADMA) Q2 2021 Earnings Call Transcript Motley Fool
Aug-11-21 06:55PM	Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments GlobeNewswire
Aug-10-21 04:30PM	ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics Persona Technology for NexSys Plasma Collection System GlobeNewswire
Aug-09-21 07:00AM	ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB® GlobeNewswire
Aug-04-21 07:00AM	ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 GlobeNewswire
Jul-28-21 03:03PM	Will Adma Biologics (ADMA) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-21-21 01:23AM	How Much Did ADMA Biologics'(NASDAQ:ADMA) Shareholders Earn From Share Price Movements Over The Last Five Years? Simply Wall St.
Jul-20-21 07:00AM	ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection GlobeNewswire
Jun-14-21 07:00AM	ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference GlobeNewswire
May-26-21 07:00AM	ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference GlobeNewswire
May-22-21 03:08AM	We Think Some Shareholders May Hesitate To Increase ADMA Biologics, Inc.'s (NASDAQ:ADMA) CEO Compensation Simply Wall St.
May-12-21 09:00PM	ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript Motley Fool
04:05PM	ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments GlobeNewswire
02:30PM	ADMA Biologics, Inc. to Host Earnings Call ACCESSWIRE
May-10-21 08:39AM	Why ADMA Biologics (ADMA) Might Surprise This Earnings Season Zacks
May-06-21 01:27AM	What Kind Of Investors Own Most Of ADMA Biologics, Inc. (NASDAQ:ADMA)? Simply Wall St. -6.29%
May-05-21 07:00AM	ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021 GlobeNewswire -5.41%
Apr-28-21 01:54PM	ADMA Biologics Increased IVIG Production Scale Gets FDA Nod; Shares Gain SmarterAnalyst +8.95%
12:34PM	Will Adma Biologics (ADMA) Report Negative Q1 Earnings? What You Should Know Zacks
08:41AM	ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin Benzinga
07:07AM	ADMA Biologics Soars as FDA Approves Increased Production TheStreet.com
07:00AM	ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale GlobeNewswire
Apr-26-21 08:00AM	ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C. GlobeNewswire
Apr-21-21 11:43AM	2 Strong Buy Penny Stocks That Could Deliver Massive Returns TipRanks +14.90%
Apr-13-21 08:00AM	ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting GlobeNewswire
Mar-25-21 07:30PM	ADMA Biologics Inc (ADMA) Q4 2020 Earnings Call Transcript Motley Fool
05:35PM	Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM	ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
Mar-18-21 08:00AM	ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021 GlobeNewswire
Mar-04-21 12:30PM	Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks -5.11%
08:00AM	ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit GlobeNewswire
Mar-03-21 08:00AM	ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections GlobeNewswire
Feb-26-21 08:00AM	ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting GlobeNewswire
Feb-22-21 08:00AM	ADMA Biologics to Participate in Raymond James Institutional Investor Conference GlobeNewswire
Feb-04-21 11:49PM	When Will ADMA Biologics, Inc. (NASDAQ:ADMA) Become Profitable? Simply Wall St.
Feb-01-21 08:00AM	ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN GlobeNewswire +10.36%
Jan-26-21 08:00AM	ADMA Biologics Receives Unique Permanent J-Code for ASCENIV GlobeNewswire
Jan-19-21 08:00AM	ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook GlobeNewswire +8.74%

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grossman Adam S	President and CEO	Oct 25	Buy	1.00	250,000	250,000	1,128,444	Oct 26 07:00 AM
Grossman Adam S	President and CEO	Oct 25	Buy	1.00	100,000	100,000	2,137,616	Oct 26 07:00 AM
LENZ BRIAN	EVP, CFO	Oct 25	Buy	1.00	30,000	30,000	1,065,501	Oct 26 07:00 AM
Grossman Jerrold B	Director	Oct 25	Buy	1.00	100,000	100,000	260,864	Oct 26 07:00 AM
KWON YOUNG	Director	Oct 25	Buy	1.00	100,000	100,000	200,000	Oct 26 07:00 AM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 30	Sale	1.12	137,495	153,994	13,262,375	Sep 30 07:27 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 29	Sale	1.16	82,505	95,706	13,399,870	Sep 30 07:27 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 28	Sale	1.22	40,603	49,536	13,482,375	Sep 30 07:27 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 27	Sale	1.23	250,000	307,500	13,522,978	Sep 29 07:18 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 24	Sale	1.26	250,000	315,000	13,772,978	Sep 29 07:18 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 23	Sale	1.27	780,000	990,600	14,022,978	Sep 28 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience